Company intelligence / Profile preview

Sekkei Bio

Bangalore, Karnataka, Indiasekkeibio.com ↗
Ownership
Private
Development stage
Preclinical
01

Overview

Sekkei Bio is an innovation-driven biopharmaceutical company focused on developing novel medicines for global unmet needs. Its proprietary platforms enable the design of multi-targeted drugs for polygenic diseases as well as next-generation mRNA-based therapeutics. The company has demonstrated proof-of-concept with SARS-CoV‑2 vaccine candidates similar to Pfizer-BioNTech/Moderna but is now advancing second-generation RNA technologies aimed at affordability and access. It also works on oral insulin delivery, thermostable insulin formulations, non-opioid analgesics, RSV combination vaccines, and nonhormonal contraceptive targets. Some programs have received funding from the Bill & Melinda Gates Foundation.

Therapeutic areas
Metabolic DisordersNeurologyInfectious Diseases
Modalities
Small moleculesPeptidesmRNA therapeutics and vaccinesBiologics (including monoclonal antibodies via mRNA)
Industry
Biotech
02

Drug pipeline

3 assets

Sekkei Bio thermostable insulin

Preclinical

2 more assets in the full pipeline.

Request access →
03

Partnerships

Collaborations with C-CAMP incubatorfunding from Bill & Melinda Gates Foundationparticipation in Accenture Women Founders Programno major pharma partnerships publicly disclosed yet.

Beyond the preview

Go deeper on Sekkei Bio.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from trial design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Licensing & deals

Full profile access

Explore licensing agreements, acquisitions, and the assets behind each deal.

  • Partners
  • Deal terms
  • Milestones

Funding history

Full profile access

Trace financing activity and the investors behind a company’s development.

  • Funding rounds
  • Investors
  • Capital raised

Competitive landscape

Full profile access

Compare peer pipelines by target, modality, and therapeutic area.

  • Peer companies
  • Targets
  • Pipeline overlap

Technologies & patents

Full profile access

Explore technology platforms and the patent landscape around relevant assets.

  • Platforms
  • Patents
  • Assignees

Research & analysis

Full profile access

Connect company news and source material to the questions you’re investigating.

  • Company news
  • Sources
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Sekkei Bio.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call